 |
Liposomal ciprofloxacin for inhalation |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2006-04-19 00:00:00 |
| Sponsor | Aradigm Corporation;3929 Point Eden Way;Hayward, California, 94545 |
Related Access Program
| |
Liposomal ciprofloxacin for inhalation |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2006-04-19 00:00:00 |
| Sponsor | Aradigm Corporation;3929 Point Eden Way;Hayward, California, 94545 |